Evidence map›Paper›PMID 40777752›Full record

ArticleChemical science2025

Correction: A supramolecular nanovehicle toward systematic, targeted cancer and tumor therapy.

Ruizheng Liang, Shusen You, Lina Ma, Chunyang Li, Rui Tian, Min Wei, Dan Yan, Meizhen Yin, Wantai Yang, David G Evans and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Ruizheng LiangState Key Laboratory of Chemical Resource Engineering, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology Beijing 100029 P. R. China weimin@mail.buct.edu.cn yinmz@mail.buct.edu.cn +86-10-64425385 +86-10-64412131.
Shusen YouState Key Laboratory of Chemical Resource Engineering, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology Beijing 100029 P. R. China weimin@mail.buct.edu.cn yinmz@mail.buct.edu.cn +86-10-64425385 +86-10-64412131.
Lina MaBeijing Shijitan Hospital, Capital Medical University Beijing 100038 P. R. China yd277@126.com.
Chunyang LiState Key Laboratory of Chemical Resource Engineering, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology Beijing 100029 P. R. China weimin@mail.buct.edu.cn yinmz@mail.buct.edu.cn +86-10-64425385 +86-10-64412131.
Rui TianState Key Laboratory of Chemical Resource Engineering, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology Beijing 100029 P. R. China weimin@mail.buct.edu.cn yinmz@mail.buct.edu.cn +86-10-64425385 +86-10-64412131.
Min WeiState Key Laboratory of Chemical Resource Engineering, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology Beijing 100029 P. R. China weimin@mail.buct.edu.cn yinmz@mail.buct.edu.cn +86-10-64425385 +86-10-64412131.
Dan YanBeijing Shijitan Hospital, Capital Medical University Beijing 100038 P. R. China yd277@126.com.
Meizhen YinState Key Laboratory of Chemical Resource Engineering, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology Beijing 100029 P. R. China weimin@mail.buct.edu.cn yinmz@mail.buct.edu.cn +86-10-64425385 +86-10-64412131.
Wantai YangState Key Laboratory of Chemical Resource Engineering, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology Beijing 100029 P. R. China weimin@mail.buct.edu.cn yinmz@mail.buct.edu.cn +86-10-64425385 +86-10-64412131.
David G EvansState Key Laboratory of Chemical Resource Engineering, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology Beijing 100029 P. R. China weimin@mail.buct.edu.cn yinmz@mail.buct.edu.cn +86-10-64425385 +86-10-64412131.
Xue DuanState Key Laboratory of Chemical Resource Engineering, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology Beijing 100029 P. R. China weimin@mail.buct.edu.cn yinmz@mail.buct.edu.cn +86-10-64425385 +86-10-64412131.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1039/C5SC00994D.].

Identifiers

PMID40777752
PMCPMC12327359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.